| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 53.8818 | 58 |
| GSM780708 | Untreated after 4 days (C2_1) | 52.4111 | 55 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.0188 | 27 |
| GSM780719 | Untreated after 4 days (C1_2) | 58.5115 | 63 |
| GSM780720 | Untreated after 4 days (C2_2) | 55.0309 | 60 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.0673 | 32 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.8572 | 44 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 53.2227 | 57 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 48.7747 | 44 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.9992 | 37 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 55.6655 | 60 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.2772 | 38 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 51.6279 | 53 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 53.3802 | 57 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 54.6687 | 59 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.0156 | 41 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 39.4888 | 5 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.3238 | 46 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 51.4216 | 53 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 53.294 | 57 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.089 | 23 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 54.7478 | 59 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.5788 | 30 |